Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation

Clinical Nephrology

Volumn 49, Issue 5, 1998, Pages 273-280

  Yoshida, S ^a   Yamada, K ^a   Hamaguch, K ^a   Nishimura, M ^a   Hatakeyama, E ^a   Tsuchida, H ^a   Sakamoto, K ^a   Kashiwabara, H ^a   Yokoyama, T ^a   Ikeda, K ^b   Horiuchi, S ^b  

^a SAKURA NATIONAL HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products (AGE); Coronary atherosclerosis; Maintenance dialysis; Renal transplantation

Indexed keywords

GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR;

ADULT; ANTIGEN BINDING; ARTERY WALL; ARTICLE; AUTOPSY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY; DIALYSIS; FEMALE; GLYCATION; HEART; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MACROPHAGE; MAINTENANCE THERAPY; MALE;

ADULT; ARTERIES; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIUM; RENAL DIALYSIS;

EID: 14444274335     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ahmed MU, Thorpe SR, Baynes JW 1986 Identification of N-carboxymetyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261: 4889-4894
2. Baynes JW 1991 Perspectives in diabetes: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412
3. Brownlee M, Vlassara H, Cerami A 1984 Nonenzymatic glycosylation and pathogenesis of diabetic complications. Ann Intern Med 101: 527-537
4. Dunn JA, Ahmed MU, Murtiashaw MH, Richardson JM, Walla D, Thrope SR, Baynes JW 1990 Reaction of ascorbate with lysine and protein under autoxidizing conditions: Formation of N∈-(carboxymetyl)lysine by reaction between lysine and products of autoxidation of ascorbate Biochemistry 29: 10964-10970
5. Hricik DE, Schulak JA, Sell DR, Fogarty JF, Monnier VM 1993 Effects of kidney or kidney-pancreatic transplantation on plasma pentosidine. Kidney Int 43: 398-403
6. Ikeda K, Higashi T, Sana H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S 1996 N∈-(carboxymethyl)lysine protein adduct is a major immunological epitope in protein modified with advanced glycation end products of the maillard reaction. Biochemistry 35: 8075-8083
7. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H 1990 Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet - derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sei USA 87: 9010-9014
8. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K 1995 Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147: 6654-6672
9. Maeda K 1995 Cause of death in 1994. In: Maeda K (ed) An overview of regular dialysis treatment (as a Dec. 31, 1994). Japanese Society for Dialysis Therapy Tokyo, Japan, pp. 68
10. Miyata T, Ueda Y, Shinzato T, lida Y, Tanaka S, van Yperesle de Strihou C, Maeda K 1996 Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patient with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7: 1198-1206
11. Miyata T, Uedu Y, Yoshida A, Iida Y, Jadoul M, Shinzato T, Maeda K, Kumsawa K, van Yperesle de Strihou C 1997 Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 51: 880-887
12. Monnier VM, Kohn RR, Cerami A 1984 Accelerated age-related browning of collagen in diabetes mellitus. Proc Natl Acad Sei USA 81: 583-587
13. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S 1997 Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51: 182-186
14. Nares S, Nf MC, Dill RE, Park B, Culter CW, lacopino AM 1996 Cyclosporin A upregulates platelets-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 67: 271-278
15. 2-microglobulin is modified with N∈-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 50: 1303-1309
16. Odetti P, Forgarry J, Sell DR, Monnier VM 1992 Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41: 153-159
17. Papanastasion P, Grass L, Rodela H, Patrikarea A, Preopuolos D, Diamandis EP 1994 Immunological quantification of advanced glycosylation endproducts in the serum of patients on hemodialysis or CAPD. Kidney Int 46: 216-222
18. Poul LC 1995 Chronic renal transplant loss. Kidney Int 47: 1491-1499
19. Roberts AB, Sporn MB, Assolan RK, Smith JM, Roche NS, Wakefield LM, Ui H, Liotta LA, Falanga V, Kehrl JH, Fauci AS 1986 Transforming growth factor-β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vivo. Proc Natl Acad Sei USA 83: 4167-4171
20. Ross R, Glomset JA 1976 The pathogenesis of atherosclerosis. N Engl J Med 295: 369-377
21. Ross R, Raines EW, Bowenpope DF 1986 The biology of plateletderived growth factor. Cell 46: 155-169
22. Russell R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809
23. Schmidt AM, Yon SD, Brett J, Mora R, Nowygrod R, Stern D 1993 Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end-products. J Clin Invest 92:1155-2168
24. Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, Sutherland DER, Najahan JS 1991 Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. Ann Surg 214: 679-688
25. Tan S-Y, Irish A, Winearls CG, Brown EA, Gower PE, Clutterbuck EJ, Madhoo S, Lavender JP, Pepys MB, Hawkins PN 1996 Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int 50: 282-289
26. Vlassara H, Brownlee M, Manogue K, Dinarello C, Pasagian A 1988 Cachectin/TNF and II-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240: 1546-1548
27. Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, Miura Y, Suzuki S, Tsuchida H, Mimura N, Araki N, Horiuchi S 1994 Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol 42: 354-361
28. Yamada K, Hamaguchi K, Hatakeyama E, Sakamoto K, Kenmochi T, Maeda H, Matsushita K, Kashiwabara H, Yokoyama T, Miura Y, Nakajima K, Ochiai T 1996 Pathophysiology in cardiovascular death of long-term survived renal transplant patients with functioning grafts. J Soc Jap Transplant 31: 60-68
29. Yamamoto T, Noble NA, Miller DE, Border WA 1994 Sustained expression of TGFβI underlies development of progressive kidney fibrosis. Kidney Int 45: 916-927